PDF-EUROPEAN MEDICINES AGENCY

ealtEMA Regulatory Science to 2025Strategic rex0066006CectionContentsForeword by Prof Guido Rasi EMA Executive Director1Vision 151 Human medicines2Vision 151 Veterinary medicines41 Introduction 151 th. emaeuropaeucontact European Medicines Agency 2014 Reproduction is authorised provided the source is acknowledged 21 July 2011 EMEACHMPEWP1922172009 Rev1 Corr Committee for Medicinal Products for Human Use CHMP Guideline on bioanalytical method vali 4420 74 18 84 00 Fax 4420 74 18 84 09 Email mailemeaeuropaeu httpwwwemeaeuropaeu EMEA 2008 Reproduction andor distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged London 11 December 2007 CPMP 4420 74 18 84 00 Fax 4420 75 23 70 51 Email mailemeaeuropaeu httpwwwemeaeuropaeu EMEA 2007 Reproduction andor distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged London 26 October 2006 Doc R (CHMP) GUIDELINE ONTHE CHOICE OF THE NON-INFERIORITY MARGIN DRAFT AGREED BY THE EFFICACY WORKING PARTY ADOPTION BY COMMITTEE FOR RELEASE FOR CONSULTATION February 2004 AGREED BY WORKING PARTY June European Medicines Agency www.ema.europa.eu Heads of Medicines Agencies www.hma.eu The European Medicines Agency is an agency of the European Union European Medicines Agency www.ema.europa .eu Heads of Medicines Agencies www.hma.eu The European Medicines Agency is an agency of the European Union The majority of international regulatory authorities are obliged by law to have systems in place to verify As an initial effort to improve international sharing of information and to facilitate more (COMMITTEE ABBREVIATION) GUIDELINE ON VIRUS SAFETY EVALUATION OF BIOTECHNOLOGICAL INVESTIGATIONAL MEDICINAL PRODUCTS DRAFT AGREED BY BWP May 2006 ADOPTION BY CHMPFOR RELEASE FOR CONSULTATION 28 Ju COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE (CVMP) GUIDELINE ON DECLARATION OF HERBAL SUBSTANCES AND HERBAL PREPARATIONS IN HERBAL MEDIC Joint Audit Programme for EEA GMP Inspectorates 7 Westferry Circus, Canary Wharf, London, E14 4HB, UK Tel. (44-20) 74 18 84 00 Fax (44-20) 74 18 85 95 E-mail: gmp@emea.europa.eu http://www.emea. Constantinos Ziogas. SME Office, Stakeholder & Communication Division, European Medicines Agency. Open Info Day. Horizon 2020 'Health, demographic change and wellbeing‘. Brussels 22 November 2013. EMA146s third public meeting 26 March 2021PCWP / HCPWP meeting 2 March 2021Nathalie BerePublic and Stakeholders Engagement DepartmentClassified as public by the European Medicines Agency ENGAGING THE The . HDA (formerly BAPW) . Who we are. Good Distribution Practice . HDA is a UK-wide representative trade association whose mission is to advance the interests and values of those member companies who provide . (CHMP) GUIDELINE ON CLINICAL INVESTIGATION OF MEDICINAL PRODUCTS FOR HORMONE REPLACEMENT THERAPY OF OESTROGEN DEFICIENCY SYMPTOMS IN POSTMENOPAUSAL WOMEN DRAFT AGREED BY THE EFFICACY WORKING PARTY